Amgen says experimental obesity drug has promising durability

Amgen says experimental obesity drug has promising durability

LOS ANGELES, Dec 3 (Reuters) – Amgen Inc’s (AMGN.O) experimental obesity drug demonstrated promising durability trends in an early trial, paving the way for a larger mid-stage study early next year, company officials said ahead of a data presentation on Saturday. The small Phase I trial found that patients maintained their weight loss for 70 … Read more

Britain’s NICE recommends against NHS use of 5 COVID treatments as not cost-effective

Britain’s NICE recommends against NHS use of 5 COVID treatments as not cost-effective

LONDON, Nov 16 (Reuters) – Britain’s agency that determines if medicines should be used in the National Health Service (NHS), has recommended stopping the use of five COVID-19 treatments, including Merck & Co’s (MRK.N)’s antiviral pill for high-risk patients, citing cost-effectiveness concerns. The review, conducted by the National Institute for Health and Care Excellence (NICE) … Read more

Roche’s Alzheimer’s drug fails to meet goal in long awaited trial

Roche’s Alzheimer’s drug fails to meet goal in long awaited trial

Trials show small benefit, but without statistical validity Roche’s setback leaves Biogen, Eisai as leaders in the field Onus on Roche CEO-designate to revive development fortunes Roche shares down 3.4%, development partner Morphosys down 29% Nov 14 (Reuters) – Roche’s (ROG.S) Alzheimer’s drug candidate could not be shown to slow dementia progression in two drug … Read more

Wall Street ends higher as investors eye U.S. midterms

Wall Street ends higher as investors eye U.S. midterms

Take-Two, Lyft slump on downbeat forecasts Amgen climbs on cholesterol drug data Indexes: S&P 500 +0.56%, Nasdaq +0.49%, Dow +1.02% Nov 8 (Reuters) – Wall Street ended higher on Tuesday during voting in midterm elections that will determine control of the U.S. Congress, with investors betting on a political stalemate that could prevent major policy … Read more

CVS, Walmart, Walgreens agree to pay $13.8 bln to settle U.S. opioid claims

CVS, Walmart, Walgreens agree to pay .8 bln to settle U.S. opioid claims

Nov 2 (Reuters) – CVS Health Corp (CVS.N), Walgreens Boots Alliance Inc (WBA.O) and Walmart Inc (WMT.N) have agreed to pay about $13.8 billion to resolve thousands of U.S. state, local and tribal government lawsuits accusing the pharmacy chains of mishandling opioid painkillers. CVS said Wednesday it had agreed to pay about $5 billion over … Read more

J&J to buy heart pump maker Abiomed for $16.6 bln ahead of consumer health spinoff

J&J to buy heart pump maker Abiomed for .6 bln ahead of consumer health spinoff

Nov 1 (Reuters) – Johnson & Johnson (JNJ.N) said on Tuesday it struck a deal to buy heart pump maker Abiomed Inc (ABMD.O) for $16.6 billion in cash, as it looks to boost growth in its medical devices unit after next year’s planned spinoff of the consumer health business. J&J agreed to pay $380 per … Read more

Pfizer expects to hike U.S. COVID vaccine price to $110-$130 per dose

Pfizer expects to hike U.S. COVID vaccine price to 0-0 per dose

NEW YORK, Oct 20 (Reuters) – Pfizer Inc expects to roughly quadruple the price of its COVID-19 vaccine to about $110 to $130 per dose after the United States government’s current purchase program expires, Pfizer executive Angela Lukin said on Thursday. Lukin said she expects the vaccine – currently provided for free to all by … Read more

Wall Street banks’ profits slide as economic clouds loom, some beat forecasts

Wall Street banks’ profits slide as economic clouds loom, some beat forecasts

Oct 14 (Reuters) – Profits slid at Wall Street’s biggest banks in the third quarter as they braced for a weaker economy while investment banking was hit hard, but investors saw a silver lining with some banks beating estimates. JPMorgan Chase & Co (JPM.N), Morgan Stanley (MS.N), Citigroup Inc (C.N) and Wells Fargo & Co’s … Read more

U.S. adds China’s YMTC and 30 other firms to ‘unverified’ trade list

U.S. adds China’s YMTC and 30 other firms to ‘unverified’ trade list

WASHINGTON, Oct 7 (Reuters) – The United States on Friday added China’s top memory chipmaker YMTC and 30 other Chinese entities to a list of companies that U.S. officials have been unable to inspect, ratcheting up tensions with Beijing and starting a 60 day-clock that could trigger much tougher penalties. The new listings were the … Read more

U.S. aims to hobble China’s chip industry with sweeping new export rules

U.S. aims to hobble China’s chip industry with sweeping new export rules

Oct 7 (Reuters) – The Biden administration on Friday published a sweeping set of export controls, including a measure to cut China off from certain semiconductor chips made anywhere in the world with U.S. tools, vastly expanding its reach in its bid to slow Beijing’s technological and military advances. The rules, some of which go … Read more